Tofacitinib for PsA: From Phase III to Approval

(MedPage Today) — In mid-December, tofacitinib was approved for use in active psoriatic arthritis Source: Dermatology

(MedPage Today) — In mid-December, tofacitinib was approved for use in active psoriatic arthritis
Source: Dermatology

Leave a Reply